---

---

symbols : TAK   

save search

---

HUTCHMED and Takeda Announce Publication of Phase III FRESCO-2 Results in The Lancet
Published: 2023-06-16 (Crawled : 01:00) - globenewswire.com
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -17.37% | O: -0.06% H: 0.53% C: -0.31%
HCM | $18.18 -0.38% 32K |

Health Technology

| 38.26% | O: 3.79% H: 4.16% C: 1.53%
publication results

---

Takeda and HUTCHMED Announce Marketing Authorization Application of Fruquintinib for Previously Treated Metastatic Colorectal Cancer Validated by the European Medicines Agency
Published: 2023-06-15 (Crawled : 14:20) - globenewswire.com
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -17.06% | O: -0.31% H: 0.78% C: 0.69%
HCM | $18.18 -0.38% 32K |

Health Technology

| 49.59% | O: 2.46% H: 9.6% C: 5.6%
authorization cancer application

---

Global Opioid Induced Constipation Markets to 2030: Revenues, Trends, Competitive Assessment & Intelligence
Published: 2023-06-09 (Crawled : 22:00) - prnewswire.com
BHC | $8.49 -0.47% 380K |

Health Technology

| Email alert Add to watchlist
AZN | News | $71.065 0.3% 3.2M |

Health Technology

| Email alert Add to watchlist
IRWD | $8.135 -2.11% 370K |

Health Technology

| Email alert Add to watchlist
GSK | News | $40.755 -1.18% 660K |

Health Technology

| Email alert Add to watchlist
GLAXF | News | $19.54 2.6K |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $140.3 1.5K |

Health Technology

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380 |

Health Technology

| Email alert Add to watchlist
PFE | News 4 | $26.185 -0.51% 6.6M |

Health Technology

| Email alert Add to watchlist
TAK | News | $13.23 -1.12% 300K |

Health Technology

| Email alert Add to watchlist
VTRS | News A | $11.37 0.09% 1.2M |

Health Technology

| Email alert Add to watchlist
opioid global

---

Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published: 2023-06-08 (Crawled : 02:00) - prnewswire.com
AZNCF | News | $140.3 1.5K |

Health Technology

| -4.49% | O: 0.07% H: 0.0% C: -1.7%
NVSEF | News | $96.0 52K |

Health Technology

| 17.13% | O: 1.32% H: 0.0% C: -0.62%
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -17.06% | O: -0.62% H: 0.88% C: 0.81%
NVS | News | $97.755 0.49% 1.1M |

Health Technology

| 0.37% | O: 1.26% H: 1.08% C: 0.91%
GSK | News | $40.755 -1.18% 660K |

Health Technology

| 20.02% | O: 0.41% H: 0.68% C: 0.64%
LLY | News | $731.81 -1.86% 1M |

Health Technology

| 69.36% | O: -0.11% H: 2.66% C: 2.24%
BMY | $48.76 -0.47% 3.9M |

Health Technology

| -24.82% | O: 0.28% H: 0.42% C: -0.05%
BNTX | News | $88.15 -0.38% 96K |

Health Technology

| -19.12% | O: 0.39% H: 0.15% C: -0.79%
AZN | News | $71.065 0.3% 3.2M |

Health Technology

| -3.36% | O: -0.23% H: 1.83% C: 1.52%
AMGN | News | $274.065 0.19% 570K |

Health Technology

| 23.63% | O: 0.0% H: 0.28% C: -0.23%
metabolic report cancer global therapeutics growth market

---

Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
Published: 2023-06-01 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $94.25 480 |

Health Technology

| -7.07% | O: -0.56% H: 0.0% C: 0.0%
AZNCF | News | $140.3 1.5K |

Health Technology

| -5.01% | O: -0.74% H: 1.4% C: 0.35%
NVSEF | News | $96.0 52K |

Health Technology

| 18.53% | O: 0.99% H: 0.0% C: 0.0%
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -16.02% | O: 1.32% H: 0.31% C: 0.12%
PFE | News 4 | $26.185 -0.51% 6.6M |

Health Technology

| -30.77% | O: 0.6% H: 1.07% C: 0.29%
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| -18.57% | O: -1.84% H: 1.62% C: 1.33%
NVS | News | $97.755 0.49% 1.1M |

Health Technology

| 1.8% | O: 1.03% H: 0.84% C: 0.82%
BMY | $48.76 -0.47% 3.9M |

Health Technology

| -24.26% | O: 0.37% H: 1.34% C: 1.14%
SNY | News | $46.82 -1.82% 510K |

Health Technology

| -6.33% | O: 1.05% H: 0.0% C: 0.0%
AZN | News | $71.065 0.3% 3.2M |

Health Technology

| -2.73% | O: 0.11% H: 0.69% C: -0.45%
report global therapeutics growth market

---

Global Addiction Treatment Market Report 2023: Sector to Reach $11.7 Billion by 2031 at a 6.1% CAGR
Published: 2023-05-26 (Crawled : 00:20) - prnewswire.com
JNJ | News | $148.22 -0.9% 3.3M |

Health Technology

| Email alert Add to watchlist
NVSEF | News | $96.0 52K |

Health Technology

| Email alert Add to watchlist
SYK | $337.47 0.76% 530K |

Health Technology

| Email alert Add to watchlist
TAK | News | $13.23 -1.12% 300K |

Health Technology

| Email alert Add to watchlist
NVS | News | $97.755 0.49% 1.1M |

Health Technology

| Email alert Add to watchlist
report reach treatment global market

---

Takeda and HUTCHMED Announce New Drug Application (NDA) for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority Review
Published: 2023-05-25 (Crawled : 23:00) - globenewswire.com
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -17.73% | O: -0.62% H: 0.62% C: -0.12%
HCM | $18.18 -0.38% 32K |

Health Technology

| 49.47% | O: 7.45% H: 3.66% C: 2.06%
drug review treatment application

---

Government of Japan Expresses its Pledge of US$200 Million to GHIT Fund/UNDP Replenishment
Published: 2023-05-25 (Crawled : 04:00) - prnewswire.com
ALPMF | News | $9.5 1.2K |

Health Technology

| -43.28% | O: 1.49% H: 0.0% C: -0.29%
ALPMY | News | $9.49 480K |

Manufacturing

| -42.97% | O: 1.2% H: 0.0% C: -0.33%
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -17.88% | O: 0.62% H: 0.0% C: -0.8%
japan

---

Targeted Therapy Global Market Report 2023: Increasing Prevalence of Cancer Drives Growth
Published: 2023-05-15 (Crawled : 17:00) - prnewswire.com
GNMSF | News | $290.34 340 |

Health Technology

| -30.92% | O: 0.24% H: 0.66% C: 0.66%
NVSEF | News | $96.0 52K |

Health Technology

| 10.61% | O: -1.1% H: 0.0% C: 0.0%
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -18.53% | O: 0.61% H: 0.3% C: 0.24%
NVS | News | $97.755 0.49% 1.1M |

Health Technology

| -4.15% | O: 0.2% H: 0.13% C: -0.22%
GSK | News | $40.755 -1.18% 660K |

Health Technology

| 12.89% | O: 0.27% H: 0.6% C: 0.41%
SNY | News | $46.82 -1.82% 510K |

Health Technology

| -13.0% | O: 0.38% H: 0.0% C: 0.0%
GMAB | News | $28.12 -1.54% 170K |

Health Technology

| -31.49% | O: 0.38% H: 0.91% C: 0.69%
AMGN | News | $274.065 0.19% 570K |

Health Technology

| 17.42% | O: 0.14% H: 0.28% C: 0.11%
report cancer global therapy growth market

---

Global Acute Repetitive Seizures Market to Showcase Promising Growth says Brandessence Market Research
Published: 2023-05-15 (Crawled : 10:00) - prnewswire.com
UCBJY | $65.26 5.9K |

Manufacturing

| 41.41% | O: 1.79% H: 0.18% C: -0.06%
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -18.53% | O: 0.61% H: 0.3% C: 0.24%
JNJ | News | $148.22 -0.9% 3.3M |

Health Technology

| -6.92% | O: 0.01% H: 0.14% C: -0.78%
LLY | News | $731.81 -1.86% 1M |

Health Technology

| 70.12% | O: 0.22% H: 0.14% C: -0.2%
ABBV | News | $168.51 -0.61% 920K |

Health Technology

| 15.22% | O: 0.35% H: 0.83% C: -0.73%
VRTX | $401.7 -0.79% 280K |

Health Technology

| 16.55% | O: 0.17% H: 1.07% C: 0.19%
SNY | News | $46.82 -1.82% 510K |

Health Technology

| -13.0% | O: 0.38% H: 0.0% C: 0.0%
GILD | $67.03 2.4M |

Health Technology

| -14.25% | O: -0.13% H: 0.42% C: 0.4%
research global growth market

---

Takeda Delivers Strong Revenue and Profit Growth in FY2022; Updated Capital Allocation Policy Reflects Deleveraging Progress and Confidence in Growth Outlook
Published: 2023-05-11 (Crawled : 09:00) - biospace.com/
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -21.41% | O: -1.83% H: 0.12% C: -3.06%
fy2022 growth

---

Global Gaucher's Disease Treatment Market Research Report 2023: Emerging Therapies, Clinical Trials, Treatments, Current Scenario Evaluation, Patient Profile
Published: 2023-05-10 (Crawled : 18:00) - prnewswire.com
NVSEF | News | $96.0 52K |

Health Technology

| 11.63% | O: 0.92% H: 0.0% C: 0.0%
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -21.41% | O: -1.83% H: 0.12% C: -3.06%
NVS | News | $97.755 0.49% 1.1M |

Health Technology

| -4.6% | O: -0.4% H: 0.34% C: 0.19%
JNJ | News | $148.22 -0.9% 3.3M |

Health Technology

| -7.42% | O: 0.11% H: 0.22% C: -0.52%
ABT | News | $106.78 -0.75% 2M |

Health Technology

| -2.8% | O: -0.57% H: 0.37% C: -0.01%
SNY | News | $46.82 -1.82% 510K |

Health Technology

| -13.01% | O: -0.28% H: 0.0% C: 0.0%
disease report treatment research global market

---

Neurocrine Biosciences Reports First Quarter 2023 Financial Results
Published: 2023-05-03 (Crawled : 12:00) - biospace.com/
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -19.71% | O: 0.36% H: 0.57% C: 0.18%
VYGR | News | $7.51 -1.83% 86K |

Health Technology

| 10.23% | O: 5.76% H: 6.4% C: 5.04%
NBIX | News M | $138.5 -1.14% 350K |

Health Technology

| 35.42% | O: 3.43% H: 0.92% C: -7.83%
financial results

---

Incyte Reports 2023 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2023-05-02 (Crawled : 12:00) - biospace.com/
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -19.8% | O: -0.42% H: 0.48% C: 0.3%
XNCR | $18.48 0.6% 110K |

Health Technology

| -32.14% | O: -0.63% H: 0.15% C: -1.78%
MOR | News | $18.05 0.06% 79K |

Health Technology

| 237.2% | O: 0.75% H: 0.0% C: -3.15%
MGNX | $15.835 -2.43% 170K |

Health Technology

| 119.03% | O: -1.62% H: 2.47% C: -6.58%
INCY | $51.4 -0.48% 380K |

Health Technology

| -31.44% | O: -9.64% H: 5.99% C: 2.76%
financial results

---

Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Report 2023: New Drug Launches and Growing Awareness Fuels $32 Billion Industry
Published: 2023-04-27 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $19.54 2.6K |

Health Technology

| 10.4% | O: 0.23% H: 0.0% C: 0.0%
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -20.85% | O: -1.13% H: 0.3% C: -0.48%
NVS | News | $97.755 0.49% 1.1M |

Health Technology

| -3.69% | O: -0.79% H: 0.89% C: 0.72%
JNJ | News | $148.22 -0.9% 3.3M |

Health Technology

| -8.18% | O: -0.12% H: 0.58% C: 0.55%
GSK | News | $40.755 -1.18% 660K |

Health Technology

| 14.52% | O: -0.25% H: 0.97% C: 0.31%
LLY | News | $731.81 -1.86% 1M |

Health Technology

| 89.33% | O: 1.96% H: 1.59% C: -0.54%
drug report treatment global growing market

---

Takeda Announces FDA Acceptance of BLA Resubmission for Investigational Subcutaneous Administration of Entyvio® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis
Published: 2023-04-27 (Crawled : 13:00) - biospace.com/
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -20.61% | O: 0.0% H: 0.36% C: 0.3%
entyvio fda active resubmission therapy

---

CBC GROUP AND MUBADALA CO-LEAD US$315 MILLION FUNDRAISING ROUND FOR HASTEN BIOPHARMA
Published: 2023-04-20 (Crawled : 06:00) - prnewswire.com
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -19.85% | O: 0.3% H: 0.0% C: -0.3%
group biopharma

---

HUTCHMED Announces NDA Acceptance in China for Fruquintinib in Second-Line Gastric Cancer
Published: 2023-04-18 (Crawled : 01:00) - globenewswire.com
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -19.99% | O: 0.9% H: 0.0% C: -0.71%
LLY | News | $731.81 -1.86% 1M |

Health Technology

| 98.48% | O: 0.17% H: 0.34% C: -0.83%
HCM | $18.18 -0.38% 32K |

Health Technology

| 8.63% | O: 1.49% H: 2.64% C: 1.52%
china

---

Global Medical Sensors Market to Reach $20,747.4 Million by 2031: Increasing Adoption of Smart Sensors in Medical Facilities Drives Growth
Published: 2023-04-14 (Crawled : 02:00) - prnewswire.com
CSLLY | $90.71 35K |

n/a

| -11.35% | O: -0.32% H: 0.0% C: -1.29%
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -20.9% | O: -0.53% H: 0.63% C: 0.18%
MDT | $80.71 -0.71% 1.9M |

Health Technology

| -0.37% | O: 0.05% H: 0.2% C: -1.13%
HON | News M | $194.77 -0.71% 830K |

Producer Manufacturing

| 0.13% | O: -0.14% H: 1.07% C: 0.47%
APH | $114.64 0.33% 3.8M |

Electronic Technology

| 45.28% | O: 0.0% H: 0.67% C: -0.65%
ON | $65.02 5.42% 4.6M |

Electronic Technology

| -20.51% | O: 0.01% H: 2.35% C: 0.41%
ADI | $196.85 3.64% 3.2M |

Electronic Technology

| 0.44% | O: -0.51% H: 1.57% C: 0.2%
global smart medical growth market

---

Global Immunoglobulins Markets, 2021-2022 & 2023-2027 with Takeda Pharmaceutical Company Limited., CSL Ltd., Grifols International SA and Kedrion SpA Dominating
Published: 2023-04-14 (Crawled : 01:00) - prnewswire.com
CSLLY | $90.71 35K |

n/a

| -11.35% | O: -0.32% H: 0.0% C: -1.29%
TAK | News | $13.23 -1.12% 300K |

Health Technology

| -20.9% | O: -0.53% H: 0.63% C: 0.18%
ADMA 4 | $6.455 -1.3% 570K |

Health Technology

| 103.11% | O: 0.0% H: 0.0% C: -1.24%
international global

---

Gainers vs Losers

54%

46%

Top 10 Gainers

CSSE 4 | $0.3499 129.74% 150M |

Consumer Services

CZOO | $11.04 121.24% 9.6M |

BOF | $2.05 75.21% 78M |

AMST | $3.2 60.0% 63M |

Technology Services

LICN | $0.8592 53.43% 13M |

WIMI | $1.05 44.75% 13M |

Technology Services

TROO | $1.51 38.53% 5.6M |

Manufacturing

MULN | News | $3.675 34.62% 11M |

Information

RILY | $27.91 28.5% 8.9M |

Finance

WHLM | $6.43 26.58% 580K |

Commercial Services

---

Your saved searches

---